The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.
Looking to clarify its expectations on manufacturer responses following inspections, the FDA earlier this year unveiled, for ...
The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
The FDA released findings from its largest test on infant formula, focused on chemical contaminants and overall safety.
A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, ...
The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project — billed as the “largest and most rigorous” to date. It found that the infant formula supply is ...
Second Nature Brands has issued a recall of its Keto Crunch Smart Mix on Friday after discovering the product may contain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results